AbbVie Inc. v. Prinston Pharmaceutical Inc. et al > Summary
Court Case Number 1:23-cv-00470
Filing Date Apr 28, 2023
Termination Date Jun 20, 2024
Court Delaware District Court
Status Dismissed - Settled
Plaintiff
Plaintiff Attorneys
12AbbVie Inc.
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
AbbVie Inc.
Attorney Name: Jeremy A. Tigan
Morris Nichols Arsht & Tunnell
AbbVie Inc.
Attorney Name: Megan E. Dellinger
Morris Nichols Arsht & Tunnell
AbbVie Inc.
Attorney Name: Jennifer H. Roscetti
Finnegan, Henderson, Farabow, Garrett & Dunner
AbbVie Inc.
Attorney Name: Danielle A. Duszczyszyn
Finnegan, Henderson, Farabow, Garrett & Dunner
AbbVie Inc.
Attorney Name: William B. Raich
Finnegan, Henderson, Farabow, Garrett & Dunner
AbbVie Inc.
Attorney Name: Constance Lee
Finnegan, Henderson, Farabow, Garrett & Dunner
AbbVie Inc.
Attorney Name: Ryan V. McDonnell
Finnegan, Henderson, Farabow, Garrett & Dunner
AbbVie Inc.
Attorney Name: Reinaldo Franqui Machin
Finnegan, Henderson, Farabow, Garrett & Dunner
AbbVie Inc.
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
AbbVie Inc.
Attorney Name: Jeremy A. Tigan
Morris Nichols Arsht & Tunnell
AbbVie Inc.
Attorney Name: Megan E. Dellinger
Morris Nichols Arsht & Tunnell
Defendant Attorneys
3Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 10682351 | Methods of administering elagolix | Jun 16, 2020 |
| 10537572 | Methods of administering elagolix | Jan 21, 2020 |
